-
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trialRidker PM, MacFadyen JG, CANTOS Trial Group et al. -
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failurePonikowski P, Voors AA, ESC Scientific Document Group. et al.
-
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)Roffi M, Patrono C, ESC Scientific Document Group.
-
Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT GuidelinesY Ueki, A Karagiannis, C Zanchin et al.
-
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesAmsterdam EA, Wenger NK, Brindis RG et al.
-
Discharge Against Medical Advice After Percutaneous Coronary Intervention in the United StatesKwok CS, Bell M, Mamas MA et al.
-
Major trials in coronary intervention from 2018Patel A, Marah N, Balan P et al.
-
Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications ConferenceJA Doll , RS Hira , KE Kearney et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
